(Hynes, 2009; Yan et al., 2018) Moreover, CCL22 produced by CD163+ TAMs binds to CCR4 on tumor cells which induces EMT and promotes HCC invasiveness in patients. The gene discussed is CD163; the disease is neoplasm.